Content about Treatment of bipolar disorder

February 17, 2011

The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

PRINCETON, N.J. — The Food and Drug Administration has approved a psychiatric drug for treating bipolar disorder when used in combination with one of two other drugs.

The FDA approved Abilify (aripiprazole), made by Bristol-Myers Squibb and Otsuka Pharmaceutical, as an adjunct to lithium or valproate for maintenance treatment of bipolar I disorder.

January 25, 2011

Nordic Naturals on Tuesday introduced its new Daily Omega brand, a line of three omega-3 products.

WATSONVILLE, Calif. — Nordic Naturals on Tuesday introduced its new Daily Omega brand, a line of three omega-3 products.

"Consumers have a large variety of products to choose from when it comes to omega-3 fatty acids, and this can be quite confusing,” stated Corinna Bellizzi, retail division sales manager for Nordic. “Daily Omega makes this choice easy by offering three concentrated formulas — two for adults and one for children — where only one soft gel is required daily to support optimal health and wellness."

December 8, 2010

The American College of Neuropsychopharmacology on Wednesday presented a new analysis of the effects of omega-3 essential fatty acids as potential treatment options for depression.

MIAMI — The American College of Neuropsychopharmacology on Wednesday presented a new analysis of the effects of omega-3 essential fatty acids as potential treatment options for depression.

Two critical omega-3 essential fatty acids available from certain food or nutritional supplements but not manufactured by the body — eicosapentenoic acid and docosahexaenoic — play a role in optimal brain functioning and have antidepressant benefits that have not been fully recognized, the professional society stated during its annual meeting in Miami.

October 28, 2010

The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency...

SILVER SPRING, Md. The Food and Drug Administration has approved a new drug for treating schizophrenia, the agency said Thursday.

The FDA announced the approval of Latuda (lurasidone hydrochloride), made by Fort Lee, N.J.-based Sunovion Pharmaceuticals. The drug is approved to treat adults with the disease, a mental illness that causes hallucinations, delusions, paranoia and disordered thinking and behavior.

October 20, 2010

The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan...

PITTSBURGH The Food and Drug Administration has approved a Mylan generic drug for Parkinson’s disease, Mylan said Thursday.

 

The drug maker announced the approval of pramipexole dihydrochloride tablets in the 0.125-mg, 0.25-mg, 0.5-mg, 1-mg and 1.5-mg strengths. The drug is a generic version of Boehringer Ingelheim’s Mirapex.

 

 

September 26, 2010

Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving...

SAN BERNARDINO, Calif, Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving away a drug used to treat the disease.

 

The chain announced Monday that it would provide 30-day supplies of the drug tamoxifen for free to patients with valid prescriptions at all of its 28 stores.

 

 

September 8, 2010

Merck's supplemental drug applications for its atypical antipsychotic received approval from the Food and Drug...

WHITEHOUSE STATION, N.J. Merck's supplemental drug applications for its atypical antipsychotic received approval from the Food and Drug Administration, the drug maker said.

Saphris now is indicated for the treatment of schizophrenia in adults, as monotherapy for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, and as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults, Merck said.

August 10, 2010

The drug market for unipolar depression will get smaller over the next decade due to...

August 9, 2010

Drug maker Angelini Labopharm has launched a new treatment for depression....

August 8, 2010

Anglo-Swedish drug maker AstraZeneca has settled 17,500 product liability cases involving one of its drugs,...

June 10, 2010

Health insurer Blue Cross Blue Shield of Texas alleged that drug maker Pfizer marketed its...

May 13, 2010

Off-label use of atypical antipsychotics may increase the risk of developing diabetes among the elderly,...

March 22, 2010

Less than a month after winning approval for treating early stages of Parkinson’s disease, a...

March 17, 2010

A state judge in New Jersey has ruled in favor of AstraZeneca in the case...

March 7, 2010

Diabetic adults with depression are twice as likely to develop dementia, according to a new...

January 20, 2010

Sandoz has launched a generic version of a drug for schizophrenia and bipolar disorder, the...

January 12, 2010

Despite a warning from the Food and Drug Administration, blood sugar and cholesterol monitoring of...

January 11, 2010

A drug made by Boehringer Ingelheim for treating Parkinson’s disease could have sales of up...

January 3, 2010

A generic drug maker has announced the availability of a treatment of the signs and...